Medicating inhibitory control? Treatment with serotonergic antidepressants predicts stop-N200 amplitudes in major depressive disorder.
Psychological medicine · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMaleFemaleMajor Depressive DisorderAdultElectroencephalographyInhibition, PsychologicalMagnetic Resonance ImagingAnxiety DisordersEvoked PotentialsSelective Serotonin Reuptake InhibitorsAntidepressive AgentsYoung AdultMiddle AgedSSRIs/SNRIsevent-related potentials (ERPs)major depression disorder (MDD)optimal full propensity matchingstop signal task (SST)Event-related potentials (ERPs)Major Depression Disorder (Mdd)Optimal Full Propensity MatchingSsris/snrisStop Signal Task (Sst)
Come citare questo studio
Wesley J B Vaught, Eric Mann, Xi Ren, Ryan J Tomm, Ricardo A Wilhelm, Makiah P Torres, Robin L Aupperle, Salvador Guinjoan, Jennifer L Stewart, Martin P Paulus, Evan J White. (2026). Medicating inhibitory control? Treatment with serotonergic antidepressants predicts stop-N200 amplitudes in major depressive disorder.. Psychological medicine. DOI: 10.1017/s0033291726106394
Consulta la pubblicazione originale ↗